For informational purposes only.
Tagon 20 tablet
Tagon 20 tablet is prescribed to control high blood sugar levels in type 2 diabetes mellitus for adult patients above 18 years of age.
Tagon 20 Tablet Composition :-
Teneligliptin ..................................... 20mg
Tagon 20 Tablet Uses :-
Tagon 20 tablet is an antidiabetic drugs, used to control type 2 diabetes mellitus (high blood sugar levels) in adult patients above 18 years of age.
Tagon 20
tablet can be used alone or in combination with other antidiabetic drugs.
When Tagon 20
tablet is used along with a healthy diet and exercise, it helps a lot in controlling blood sugar.
Dosage Forms & Strengths :-
Tagon 20 Tablet Dosage :-
Tagon 20
tablet is a prescription medicine. Take Tagon 20
tablet as directed by your doctor. Use Tagon 20
tablet exactly as directed by the doctor. Do not take a higher or lower dose than directed by your doctor. Tagon 20
tablet should be taken immediately before or with a meal. Never self-medicate or change the dosage without a doctor's advice.
Do not take 2 or more doses at the same time.
Always try to take Tagon 20 tablet on regular schedule. Always take the tablet even if you feel well or your blood sugar level is under control. Do not stop taking without your doctor's advice. Otherwise, your blood sugar level may rise again. Do not stop taking Tagon 20 tablet without asking your doctor. Because the treatment of diabetes is lifelong.
How Does Tagon 20 tablet ( Teneligliptin ) Work :-
Tagon 20
tablet contains : Teneligliptin.
Teneligliptin :
Teneligliptin is an dipeptidyl peptidase 4 (DPP-4) inhibitors class antidiabetic drugs. Teneligliptin works by increasing the amount of insulin produced by pancreas. Teneligliptin works by decreasing the hormones that raise blood sugar levels in the pancreas. Teneligliptin lowers your blood sugar level, and controls the amount of glucose in the blood.
Thus Tagon 20 tablet works by controlling the level of sugar in the blood.
Tagon 20 Tablet Sideeffects :-
Low blood sugar (hypoglycemia),
Constipation,
Dizziness,
Diarrhea,
Fever,
Precautions :-
Pregnancy :
Teneligliptin should not be used in pregnant women. If the medical benefits outweigh the potential risks associated with the treatment. Because in animal studies (mice) transferor has been reported to the fetus
Lactation :
For lactating women or during breastfeeding use only if prescribed by a doctor. Because it is unsafe to use during breastfeeding, or breastfeeding should be stopped.
Pediatric Use :
in a low birth weight baby, newborn, infant, or young child The safety of teneligliptin has not been established.
Geriatric Use :
Elderly patients often usually have physiological hypofunction; Teneligliptin should therefore be administered with caution.
Use in patients with renal Impairment :
Teneligliptin is safe to use in patients with renal impairment, as there is no significant risk associated with increased exposure to teneligliptin in patients with renal impairment. And no dosage adjustment is proposed in patients with renal impairment.
Use in patients with hepatic impairment :
Teneligliptin is safe to use in patients with hepatic impairment because the extent of increased exposure to teneligliptin in patients with mild to moderate hepatic impairment does not pose any significant risk. And no dosage adjustment is proposed in patients with mild to moderate hepatic impairment. No experience is available on the use of teneligliptin in patients with severe hepatic impairment.
Tagon 20 tablet Price:-
MRP ₹ : 186.00 ( 15 tabs )
MRP ₹ : 186.00 ( 15 tabs )
Packing Information :-
Tagon 20
tablet is available in pack of 15 tablets.
Tagon 20
tablet is available in pack of 15 tablets.
Tagon 20 tablet Marketed By :-
Intas Pharmaceuticals Ltd
Intas Pharmaceuticals Ltd
Tagon 20 tablet Self life :-
Please see the expiry date/manufacture date printed on Tagon 20
tablet pack.
Please see the expiry date/manufacture date printed on Tagon 20
tablet pack.
Classification :-
Therapeutic Class - Antidiabetic drugs, Dipeptidyl peptidase 4 (DPP-4) inhibitors,
Information on this page was last updated on 17 September 2021